KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL) Fair Value & Analysis

Consumer Non-Cyclicals · IN · Market cap ₹689M

Below-average quality, and screening another 42% overvalued on our models.

What matters now

• The price sits above even our optimistic bull case (₹38.72). The favourable scenario is already priced in.
• Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts.
• The model range is unusually wide (₹10.54 to ₹38.72). The outcome hinges heavily on assumptions, so read the point estimate with caution.
• The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range ₹34.01 – ₹126.15 · fair‑value band ₹10.54 – ₹38.72 · the ₹42.15 price screens above the ₹24.63 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

KOTHARI FERMENTATION & BIOCHEM LTD. (KFBL) currently trades at ₹42.15, while our model-based Fair Value estimate is ₹24.63, implying the stock looks roughly 41.6% overvalued today. The Quality Score stands at 43/100 (below-average quality), in the Consumer Non-Cyclicals sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, KOTHARI FERMENTATION & BIOCHEM LTD. generated revenue of ₹1.1B at a net margin of -2.7%. Revenue grew 0.9% year over year. It earns a return on equity of -5.4%. Net debt stands at ₹476M. Fundamentals as of Aug 13, 2026

Our scenario range runs from ₹10.54 (bear case) to ₹38.72 (bull case); at ₹42.15, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 40% below its 52-week high and 40% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at 11% fair-value upside, at -42%, KFBL screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: Multiples (₹28.03) versus Asset-Based (₹24.10). Highest evidence: EV/EBITDA (54).

Key figures & financial health

Quality Score breakdown

About the company

Kothari Fermentation and Biochem Limited manufactures and sells yeast and its derivatives in India. It offers distiller's instant yeast for use in alcohol fermentation; fresh, instant, and inactive dried yeast for use in the food industry; yeast extract powder and inactive dried yeast for use in the pharmaceutical industry; and live yeast and oligo …

Full company description

Kothari Fermentation and Biochem Limited manufactures and sells yeast and its derivatives in India. It offers distiller's instant yeast for use in alcohol fermentation; fresh, instant, and inactive dried yeast for use in the food industry; yeast extract powder and inactive dried yeast for use in the pharmaceutical industry; and live yeast and oligo saccharides for use in the veterinary industry. The company offers its products under the Sunrise, KF, and Four Seasons brand names. Kothari Fermentation and Biochem Limited also exports its products to various countries. The company was incorporated in 1990 and is based in New Delhi, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

KOTHARI FERMENTATION & BIOCHEM LTD. reported revenue of ₹1.1B in FY2026 versus ₹970M in FY2022, a compound +3.7%/yr. Reported net income was −₹29.9M in FY2026.

KFBL screens 42% overvalued. Compare with FB →

Peer Group

Food & Tobacco · 17 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Food & Tobacco stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Explore undervalued stocks

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.